Provided by Tiger Trade Technology Pte. Ltd.

Dianthus Therapeutics Inc.

82.45
+2.843.57%
Post-market: 83.370.9200+1.12%17:23 EDT
Volume:1.56M
Turnover:128.90M
Market Cap:4.17B
PE:-19.61
High:84.75
Open:79.98
Low:79.10
Close:79.61
52wk High:88.02
52wk Low:13.37
Shares:50.54M
Float Shares:45.13M
Volume Ratio:1.26
T/O Rate:3.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.2037
EPS(LYR):-4.2037
ROE:-38.38%
ROA:-24.58%
PB:8.44
PE(LYR):-19.61

Loading ...

Dianthus Therapeutics; Director Paula Soteropoulos drops 27,594 common shares worth $2,153,736

Reuters
·
2 hours ago

Dianthus Therapeutics- Proposed Changes to Screening Criteria Related to Claseprubart Trials to FDA in Q1 2026 - SEC Filing

THOMSON REUTERS
·
Yesterday

U.S. RESEARCH ROUNDUP-Carnival, Five Below, McKesson

Reuters
·
Mar 19

Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH) and Minerva Neurosciences (NERV)

TIPRANKS
·
Mar 16

Dianthus Chief Accounting Officer Edward Carr Disposes of Common Shares

Reuters
·
Mar 14

Dianthus price target raised to $103 from $80 at Wedbush

TIPRANKS
·
Mar 12

Analysts Have Conflicting Sentiments on These Healthcare Companies: Nanobiotix (NBTX), ImageneBio (IMA) and Dianthus Therapeutics (DNTH)

TIPRANKS
·
Mar 12

Dianthus Therapeutics prices upsized follow-on offering at USD 625 million

Reuters
·
Mar 11

Dianthus Therapeutics Inc - Prices Upsized Offering of 7,313,582 Shares at $81.00 per Share

THOMSON REUTERS
·
Mar 11

Stock Track | Dianthus Therapeutics Soars 5.09% Intraday on Multiple Analyst Upgrades and Price Target Increases

Stock Track
·
Mar 11

Dianthus price target raised to $80 from $55 at Wedbush

TIPRANKS
·
Mar 10

Dianthus Therapeutics Inc : Raymond James Raises to Strong Buy From Outperform; Raises Target Price to $123 From $63

THOMSON REUTERS
·
Mar 10

U.S. RESEARCH ROUNDUP-Adobe, Caseys General Stores, FedEx

Reuters
·
Mar 10

AI Integration Exposes Dianthus Therapeutics to Heightened Cyber, Privacy, and Reputational Risks

TIPRANKS
·
Mar 10

BRIEF-Dianthus Therapeutics Announces Proposed $400 Million Underwritten Public Offering

Reuters
·
Mar 10

Dianthus Therapeutics Shares Down 4.1% After the Bell; Announces Proposed $400 Million Underwritten Public Offering

THOMSON REUTERS
·
Mar 10

Dianthus announces $400M common stock offering

TIPRANKS
·
Mar 10

Dianthus Therapeutics Inc - to Use Net Proceeds for Clinical, Commercial, Working Capital, and Corporate Purposes

THOMSON REUTERS
·
Mar 10

Dianthus price target raised to $98 from $81 at Jefferies

TIPRANKS
·
Mar 10

Top Midday Gainers

MT Newswires Live
·
Mar 10